FindTrial
Sign In

An observational study on Macular Telangiectasia Type 2 characteristics using different imaging modalities in Indian population

Clinical profile and multimodal imaging characteristics of Macular Telangiectasia Type 2 in Indian population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046686
Enrollment
53
Registered
2022-10-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H353- Degeneration of macula and posterior pole

Interventions

None listed

Sponsors

Aravind Eye Hospital Chennai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive patients with clinical suspicion of Macular Telangiectasia Type 2 above 30 years of age attending Aravind Eye Hospital Out Patient Department

Exclusion criteria

Exclusion criteria: co-existing macular pathology prior vitreoretina surgery severe media opacity precluding grading of image pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Documenting the status of Macular Telangiectasia Type 2 using multimodal imaging helps in grading severity and hence benefits the patient. This study is done to correlate findings of multimodal imaging with visual acuity.Timepoint: The study helps to understand the pathogenesis by novel clinical findings which could aid in treatment in future studies—

Secondary

MeasureTime frame
The study helps to analyze the natural history of the disease which could aid in future interventional studies.Timepoint: The study is done for 6 months period.—

Countries

India

Contacts

Public ContactSugannya B S

Aravind Eye Hospital

anandr@aravind.org04440956100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026